LVN Critical Thinking Quiz: Prostate Health

What is Benign Prostatic Hyperplasia (BPH)?

• A non-cancerous enlargement of the prostate gland

• A malignant tumor in the prostate

• An infection of the prostate gland

• A condition affecting only young males

Answer explanation

Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland, leading to urinary symptoms. It is not a malignant tumor, an infection, nor limited to young males.

Which of the following are clinical manifestations of BPH?

• Urinary frequency, urgency, nocturia

• Back pain, hip pain, weight loss

• Elevated PSA levels

• Hard, irregular prostate

Answer explanation

The correct choice, urinary frequency, urgency, and nocturia, are common clinical manifestations of Benign Prostatic Hyperplasia (BPH), caused by bladder outlet obstruction. The other options are not typical symptoms of BPH.

What is the purpose of the International Prostate Symptom Score (I-PSS)?

• To evaluate the severity and effect of BPH on quality of life

• To diagnose prostate cancer

• To measure prostate size

• To determine the need for surgery

Answer explanation

The I-PSS is designed to assess the severity of symptoms related to benign prostatic hyperplasia (BPH) and their impact on a patient's quality of life, making it crucial for understanding symptom burden.

Which medication is used to shrink the prostate over 6 months?

• 5-alpha reductase inhibitors (finasteride)

• Alpha-blockers (tamsulosin)

• PDE-5 inhibitors (tadalafil)

• Antibiotics

Answer explanation

5-alpha reductase inhibitors, like finasteride, are specifically designed to shrink the prostate over time, typically taking about 6 months to show significant results. Other options do not have this effect.

What is the most common surgical procedure for BPH?

• TURP (Transurethral Resection of Prostate)

• Prostatectomy

• TUNA (Radiofrequency needle ablation)

• TUMT (Microwave therapy)

Answer explanation

TURP (Transurethral Resection of Prostate) is the most common surgical procedure for BPH, as it effectively removes prostate tissue to relieve urinary symptoms, making it a standard treatment option.

What should be monitored postoperatively after TURP?

• Continuous bladder irrigation (CBI)

• Blood pressure

• Heart rate

• Respiratory rate

Answer explanation

After TURP, Continuous Bladder Irrigation (CBI) is crucial to prevent clot formation and ensure proper urine flow. Monitoring CBI helps detect complications early, making it the primary focus in postoperative care.

What is a risk factor for prostate cancer?

• Age over 65

• Low-fat diet

• High-fiber diet

• Regular exercise

Answer explanation

Age over 65 is a significant risk factor for prostate cancer, as the likelihood of developing the disease increases with age. The other options, such as diet and exercise, do not have the same level of established risk association.

Which of the following is a treatment option for prostate cancer?

• Hormonal therapy (androgen deprivation)

• Antibiotics

• Painkillers

• Dietary supplements

Answer explanation

Hormonal therapy (androgen deprivation) is a standard treatment for prostate cancer, as it reduces levels of male hormones that can fuel cancer growth. The other options listed are not effective treatments for this condition.

What should LVNs monitor in patients with prostate cancer?

• Signs of urinary obstruction

• Blood glucose levels

• Cholesterol levels

• Liver function tests

Answer explanation

LVNs should monitor for signs of urinary obstruction in patients with prostate cancer, as the disease can lead to complications affecting urinary function. Other options are not directly related to prostate cancer management.

Which diagnostic test is commonly used to assess prostate size in BPH?

• Colonoscopy

• Chest X-ray

• Electrocardiogram (ECG)

• Transrectal ultrasound (TRUS)

Answer explanation

Transrectal ultrasound (TRUS) is the standard diagnostic test used to evaluate prostate size in benign prostatic hyperplasia (BPH), providing clear imaging of the prostate.